Cleared Traditional

K190130 - The ClearSight finger cuffs

K190130 is an FDA 510(k) clearance for The ClearSight finger cuffs, manufactured by Edwards Lifesciences, LLC. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 144-day FDA review.

K190130 · Edwards Lifesciences, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2019
Decision
144d
Days
Class 2
Risk

K190130 is an FDA 510(k) clearance for the The ClearSight finger cuffs. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Edwards Lifesciences, LLC (Irvine, US). The FDA issued a Cleared decision on June 21, 2019 after a review of 144 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Edwards Lifesciences, LLC devices

FDA 510(k) Submission Details - K190130

510(k) Number K190130 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 28, 2019
Decision Date June 21, 2019
Days to Decision 144 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
19d slower than avg
Panel avg: 125d · This submission: 144d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 565
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K190130.
Microlife Upper Arm Automatic Digital Blood Pressure Monitor
K190818 · Microlife Intellectual Property GmbH · Jul 2019
Arm-type Electronic Blood Pressure Monitor
K183058 · Shenzhen Bsx Technology Electronics Co., Ltd. · Jul 2019
Oscillometric Blood Pressure Monitor
K190927 · Rudolf Riester GmbH · Jun 2019
Full Automatic (NIBP) Blood Pressure Monitor-HL158UB
K190133 · Health & Life Co., Ltd. · Jun 2019
Fully Automatic Electronic Blood Pressure Monitor
K183535 · Andon Health Co, Ltd. · Jun 2019
Full Automatic (NIBP) Blood Pressure Monitor-HL158TB
K190134 · Health & Life Co., Ltd. · May 2019